0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Treatment of Generalized Granuloma Annulare with Oral Griseofulvin

      case-report
      ,
      Case Reports in Dermatological Medicine
      Hindawi

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Granuloma annulare (GA) is a benign skin disease that has four clinical variants including localized, generalized, perforating, and subcutaneous GA. The most common type is localized GA, followed by generalized GA. Generalized GA was defined as at least 10 widespread annular plagues and frequently on the trunk, face, neck, and extremities. The diagnosis was made by clinical and histopathology. Generalized GA was difficult to treat. Case Presentation. We presented a Thai woman with nonscaly annular papules and plaques on the trunk and all extremities. A skin biopsy revealed a lesion that was compatible with granuloma annulare. She was partially resolved with 2-month course of oral griseofluvin 500 mg daily. Discussion. The regression of GA response to oral griseofulvin is consistent with the inflammatory nature, which identified IFN-gamma upregulated in GA.

          Conclusion

          Griseofulvin is safe with few side effects and cost effectiveness. Further studies are needed to better understand the immunology and pathogenesis of GA.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Granuloma annulare

          Granuloma annulare (GA) represents a cutaneous reaction pattern of unknown cause with a variety of previously described potential disease associations and triggers. This review attempts to synthesize the available data regarding potential etiopathogenesis, reviews the available data on potential GA disease associations and work-up indicated for patients with GA, and discusses potential inciting triggers. In the final part, this article describes the available treatments options and supporting data, and provides a framework for approaching management of patients with GA. The previous accompanying article provided a comprehensive overview of the available information known about the clinical variants, epidemiology, genetics, and histology of GA.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options

            Granuloma annulare (GA) is an inflammatory granulomatous skin disease that can be localized (localized GA) or disseminated (generalized GA), with patch, perforating, and subcutaneous subtypes being less common variants of this benign condition. Recently, new research has emerged that further elucidates GA epidemiology and etiopathogenesis; importantly, new therapeutic options for GA have also been described, although there remains a paucity of randomized controlled studies. In this review, we summarize recent updates on GA epidemiology and etiopathogenesis and offer an updated review of the therapeutic options for GA currently reported in the literature. We hope that the current review galvanizes randomized controlled studies that will in turn help lead to the recommendation of evidence-based treatments for GA.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Granuloma annulare skin profile shows activation of Th1, Th2, and JAK pathways

              Granuloma annulare (GA) is an inflammatory skin disorder. Localized GA is often self-resolving, but generalized GA is often recalcitrant to treatments. There are no targeted treatments for GA, largely due to lack of mechanistic understanding. Recently, tumor necrosis factor antagonism showed promise in GA, suggesting an underlying immune pathogenesis.
                Bookmark

                Author and article information

                Contributors
                Journal
                Case Rep Dermatol Med
                Case Rep Dermatol Med
                CRIDM
                Case Reports in Dermatological Medicine
                Hindawi
                2090-6463
                2090-6471
                2022
                18 November 2022
                : 2022
                : 2523710
                Affiliations
                Institute of Dermatology, Bangkok, Thailand
                Author notes

                Academic Editor: Alireza Firooz

                Author information
                https://orcid.org/0000-0002-7401-6596
                Article
                10.1155/2022/2523710
                9699782
                36440185
                5e6a36d2-a949-44dd-801e-060e68a324a1
                Copyright © 2022 Chumsaeng Chumsaengsri and Jongjin Suwanthaweemeesuk.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 15 July 2022
                : 4 November 2022
                : 8 November 2022
                Categories
                Case Report

                Dermatology
                Dermatology

                Comments

                Comment on this article